Evidence map›Paper›PMID 32500117›Full record

ArticleNature metabolism2020

T1D progression is associated with loss of CD3

Giuseppe Terrazzano, Sara Bruzzaniti, Valentina Rubino, Marianna Santopaolo, Anna Teresa Palatucci, Angela Giovazzino, Claudia La Rocca, Paola de Candia, Annibale Puca, Francesco Perna and 13 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TInternational journal of molecular sciences · 2024
    Article
  6. Immune Profile in COVID-19: Unveiling TInternational journal of molecular sciences · 2024
    Article
  7. Involvement of KAntioxidants (Basel, Switzerland) · 2024
    Article
  8. Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8Neurology(R) neuroimmunology & neuroinflammation · 2024
    Article
  9. Article
  10. Regulatory TCells · 2023
    Review
  11. Article
  12. Article
  13. Clinical and experimental treatment of type 1 diabetes.Clinical and experimental immunology · 2022
    Review
  14. Bone marrow CD3European journal of haematology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 2 countries.

Giuseppe Terrazzano *Dipartimento di Scienze, Università degli Studi di Potenza, Potenza, Italy.
Sara Bruzzaniti *Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Valentina Rubino *Dipartimento di Scienze, Università degli Studi di Potenza, Potenza, Italy.
Marianna SantopaoloLaboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Anna Teresa PalatucciDipartimento di Scienze, Università degli Studi di Potenza, Potenza, Italy.
Angela GiovazzinoDipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Naples, Italy.
Claudia La RoccaLaboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Paola de CandiaIstituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milan, Italy.
Annibale PucaIstituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milan, Italy.
Francesco PernaDipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Naples, Italy.
Claudio ProcacciniLaboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Veronica De RosaLaboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Chiara PorcelliniDipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Naples, Italy.
Salvatore De SimoneLaboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Valentina FattorussoDipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Naples, Italy.
Antonio PorcelliniDipartimento di Biologia, Università degli Studi di Napoli Federico II, Naples, Italy.ORCID http://orcid.org/0000-0001-6882-9518
Enza MozzilloDipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Naples, Italy.
Riccardo TronconeDipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Naples, Italy.
Adriana FranzeseDipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Naples, Italy.
Johnny LudvigssonDivision of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University and Crown Princess Victoria Children's Hospital, Linköping, Sweden.ORCID http://orcid.org/0000-0003-1695-5234
Giuseppe MatareseLaboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy. giuseppe.matarese@unina.it.ORCID http://orcid.org/0000-0001-9429-0616
Giuseppina RuggieroDipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Naples, Italy. giruggie@unina.it.ORCID http://orcid.org/0000-0002-8975-6001
Mario GalganiLaboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale G. Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy. mario.galgani@unina.it.ORCID http://orcid.org/0000-0001-8414-1676
University of Naples Federico II · ITInstitute for Experimental Endocrinology and Oncology · ITCeinge Biotecnologie Avanzate (Italy) · ITMultiMedica · ITLinköping University Hospital · SE

Funding

European Research Council 310496
6 · The paper itself

Abstract

An unresolved issue in autoimmunity is the lack of surrogate biomarkers of immunological self-tolerance for disease monitoring. Here, we show that peripheral frequency of a regulatory T cell population, characterized by the co-expression of CD3 and CD56 molecules (T

Indexed as

BiomarkersCD3 ComplexCD56 AntigenCD8-Positive T-LymphocytesChildDiabetes Mellitus, Type 1Disease ProgressionFemaleHumansMaleMonitoring, ImmunologicT-Lymphocytes, RegulatoryBiomarkersCD3 ComplexCD56 Antigen

Identifiers

PMID32500117
PMCPMC7272221
OpenAlexW3006034040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.